Clinical Trials Logo

Clinical Trial Summary

This is a multicentre, open-label, randomised, phase III study designed to evaluate the efficacy and safety of Actilyse 2 mg/2 ml in the restoration of function of CVAD


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01958164
Study type Interventional
Source Boehringer Ingelheim
Contact
Status Completed
Phase Phase 3
Start date September 2013
Completion date April 2014

See also
  Status Clinical Trial Phase
Completed NCT06290284 - Comparison Between Mini-midline and the Peripheral Intravenous Catheter N/A
Recruiting NCT02556541 - Ultrasound-guided Peripheral Vascular Access in Children N/A
Completed NCT04086693 - Peripheral Intravenous Catheter Securement With Tissue Adhesive N/A
Recruiting NCT04692753 - Effect of Education of Health Care Workers on the Maintenance of Venous Access Devices
Completed NCT05378568 - Implementation and Evaluation of the Selection Scheme of Peripheral Venous Infusion Devices for Hospitalized Children N/A
Completed NCT02770560 - Efficacy of Urokinase Containing Locking Solutions for Thrombotic Dysfunction of Tunneled Hemodialysis Catheters N/A
Completed NCT03996733 - Using A Gelatin-Based Model In USG-Guided Jugular Venous Catheter Placement Training N/A
Completed NCT03502980 - Safety and Efficacy of Midline and PICC N/A
Completed NCT06355466 - Tunneled Hemodialysis Catheters as Permanent Vascular Access: Evaluating One-year Patency Rate and Affecting Factors
Recruiting NCT05884294 - Midline Catheter Versus Long Peripheral Intravenous Catheter in Hospitalized Adult Patients N/A